{
    "clinical_study": {
        "@rank": "114272", 
        "arm_group": [
            {
                "arm_group_label": "Fish Oil Supplementation", 
                "arm_group_type": "Experimental", 
                "description": "Patients will receive fish oil capsules, at a dose of 4g/day. Each 1g capsule will contain 220mg of EPA and 170mg of DHA."
            }, 
            {
                "arm_group_label": "Flaxseed Oil Supplementation", 
                "arm_group_type": "Experimental", 
                "description": "Patients will receive flaxseed oil capsule, at a dose of 4g/day. Each 1g capsule will contain 550mg of ALA"
            }, 
            {
                "arm_group_label": "Placebo Supplementation", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Patients will receive corn oil in the capsules at the same dose as fish oil. The corn oil will appear identical in size and color to the fish oil."
            }
        ], 
        "brief_summary": {
            "textblock": "This study is to examine the change of fasting insulin, glucose, insulin sensitivity and\n      related traits in response to the six month treatment of omega-3 fatty acids, including fish\n      oil and flaxseed oil, in Chinese type 2 diabetic patients. Corn oil, rich in omega-6 fatty\n      acids, will be selected as a controlled oil. The investigators hypothesize that omega-3\n      fatty acids could improve insulin sensitivity and glucose metabolism in Chinese type 2\n      diabetic patients."
        }, 
        "brief_title": "Effect of Omega-3 Fatty Acids on Insulin Sensitivity in Chinese Type 2 Diabetic Patients", 
        "condition": [
            "Type 2 Diabetes", 
            "Insulin Resistance"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus, Type 2", 
                "Insulin Resistance"
            ]
        }, 
        "detailed_description": {
            "textblock": "The insulin resistance will be estimated by a homeostatic model assessment model of insulin\n      resistance (HOMA-IR)"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Fasting glucose between 7.0 and 14.0 mmol/L, and HbA1c<9%;\n\n          2. Male, 40-70 years; female, postmenopausal to 70 years;\n\n          3. Agree to participant in the trial.\n\n        Exclusion Criteria:\n\n          1. Deny to sign the informed consent;\n\n          2. type 1 diabetes;\n\n          3. Family history of hypertriglyceridemia or fasting triglyceride>4.56 mmol/L;\n\n          4. Have severe liver disease, kidney disease or cancer;\n\n          5. Participating in the other clinical trial within 30 days;\n\n          6. Other diseases or conditions, for which the doctor of the patients do not agree his\n             or her participating."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "324", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01857167", 
            "org_study_id": "DUOLI2013011"
        }, 
        "intervention": [
            {
                "arm_group_label": "Fish Oil Supplementation", 
                "intervention_name": "Fish Oil Supplementation", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Flaxseed Oil Supplementation", 
                "intervention_name": "Flaxseed Oil Supplementation", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Placebo Supplementation", 
                "intervention_name": "placebo", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "omega-3 fatty acids", 
            "randomized controlled trial"
        ], 
        "lastchanged_date": "July 27, 2013", 
        "location": [
            {
                "contact": {
                    "email": "fangling9999@sina.com", 
                    "last_name": "Ling Fang, Ph.D"
                }, 
                "facility": {
                    "address": {
                        "city": "Lanzhou", 
                        "country": "China", 
                        "state": "Gansu"
                    }, 
                    "name": "Gansu Second People's Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "duoli@zju.edu.cn", 
                    "last_name": "Duo Li, Ph.D.", 
                    "phone": "+86 571 88982024"
                }, 
                "facility": {
                    "address": {
                        "city": "Hangzhou", 
                        "country": "China", 
                        "state": "Zhejiang", 
                        "zip": "310058"
                    }, 
                    "name": "Zhejiang University"
                }, 
                "investigator": {
                    "last_name": "Duo Li, Ph.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "3", 
        "overall_contact": {
            "email": "duoli@zju.edu.cn", 
            "last_name": "Duo Li, Ph.D.", 
            "phone": "86+571 88982024"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee of the College of Biosystem Engineering & Food Science, Zhejiang University"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "insulin resistance", 
            "safety_issue": "No", 
            "time_frame": "180 days"
        }, 
        "reference": {
            "PMID": "22984522", 
            "citation": "Zheng JS, Huang T, Yang J, Fu YQ, Li D. Marine N-3 polyunsaturated fatty acids are inversely associated with risk of type 2 diabetes in Asians: a systematic review and meta-analysis. PLoS One. 2012;7(9):e44525. doi: 10.1371/journal.pone.0044525. Epub 2012 Sep 11. Review."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01857167"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Zhejiang University", 
            "investigator_full_name": "Duo li", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Zhejiang University", 
        "sponsors": {
            "collaborator": {
                "agency": "National Natural Science Foundation of China", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Zhejiang University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}